| 摘要 |
The present invention relates to a method for selectively amplifying the oligomerization of at least one PrP Sc isoform of the PrP C cellular prion protein, characterized in that it comprises bringing said PrP Sc isoform, under conditions suitable for amplification, together with an effective amount of at least one compound of general formula I as follow: The instant invention is also directed to new compounds of formula I and pharmaceutical compositions including them.
|
